Mechanisms for linezolid-induced anemia and thrombocytopenia

Annals of Pharmacotherapy

Volumn 37, Issue 4, 2003, Pages 517-520

  Bernstein, Wendy B ^a,b   Trotta, Richard F ^c,d   Rector, James T ^c,e   Tjaden, Jeffery A ^c   Barile, Anthony J ^c,f   Martínez, Mirza D ^g   Mallet, Louise ^g  

^a WRAIR   (United States)

^b Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

^d US Army Health Clinic   (Italy)

^e Naval Ambulatory Care Center   (United States)

^f MIMA Cancer Center   (United States)

^g MIMA ^*

Author keywords

Immune thrombocytopenia; Intravenous gammaglobulin; Linezolid; Ringed sideroblasts

Indexed keywords

CLOPIDOGREL; DILTIAZEM; ERYTHROPOIETIN; FUROSEMIDE; GENTAMICIN; HEPARIN; IMMUNOGLOBULIN; INSULIN DERIVATIVE; IPRATROPIUM BROMIDE; LEVOFLOXACIN; LINEZOLID; METOLAZONE; PARACETAMOL; RANITIDINE; SALBUTAMOL; TRIAMCINOLONE ACETONIDE; VANCOMYCIN;

AGED; ANEMIA; ARTICLE; BACTERIAL ENDOCARDITIS; BONE MARROW BIOPSY; CASE REPORT; CONGESTIVE HEART FAILURE; DISEASE COURSE; DRUG MECHANISM; DYSERYTHROPOIESIS; FEMALE; HISTOPATHOLOGY; HUMAN; KIDNEY FAILURE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; SIDEROBLASTIC ANEMIA; STAPHYLOCOCCUS EPIDERMIDIS; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ACETAMIDES; AGED; ANEMIA; DRUG HYPERSENSITIVITY; ENDOCARDITIS, BACTERIAL; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; OXAZOLIDINONES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; THROMBOCYTOPENIA; TIME FACTORS;

EID: 0037380765     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1C361     Document Type: Article

References (14)

1. Linezolid (Zyvox). Med Lett 2000;42:45-6.
2. Green SL, Maddox JC, Huttenbach ED. Linezolid and reversible myelosuppression (letter). JAMA 2001;285:1291.
3. Kuter DJ, Tillotson GS. Hematologic effects of antimicrobials: focus on the oxazolidinone linezolid. Pharmacotherapy 2001;21:1010-3.
4. Waldrep T, Skiest DJ. Linezolid-induced anemia and thrombocytopenia. Pharmacotherapy 2002;22:109-12.
5. Attassi K, Hershberger E, Alam R, Zervos MJ. Thrombocytopenia associated with linezolid therapy. Clin Infect Dis 2002;34:695-8.
6. Kaufman DW, Kelly JP, Johannes CB, Sandler A, Harmon D, Stolley PD, et al. Acute thrombocytopenic purpura in relation to the use of drugs. Blood 1993;82:2714-8.
7. Chong BH, Du X, Berndt MC, Horn S, Chesterman CN. Characterization of the binding domains on platelet glycoproteins Ib-IX and IIb/IIIa complexes for the quinine/quinidine dependent antibodies. Blood 1991;77: 2190-9.
8. Warkentin TE, Chong BH, Greinacher A. Heparin-induced thrombocytopenia: towards consensus. Thromb Haemost 1998;79:1-7.
9. Kelton JG, Smith JW, Warkentin TE, Hayward CP, Denomme GA, Horsewood P. Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4. Blood 1994;83:3232-9.
10. Yu Z, Lennon VA. Mechanism of intravenous immune globulin therapy in antibody mediated autoimmune diseases. N Engl J Med 1999;340:227-8.
11. Young NS. Acquired aplastic anemia. In: Young NS, ed. Bone marrow failure syndromes. Philadelphia: WB Saunders, 2000:17-8.
12. Swaney SM, Aoki H, Ganoza MC, Shinabarger DL. The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria. Antimicrob Agents Chemother 1998;42:3251-5.
13. Dickema DJ, Jones RN. Oxazolidinones. A review. Drugs 2000;59:7-16.
14. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.